latest thinking on treating osteoporosis in postmenopausal women

April 2002

Here's the latest thinking on treating osteoporosis in postmenopausal women.

Fosamax and Actonel are widely-used oral bisphosphonates. They increase bone density and prevent fractures by inhibiting bone resorption. But some patients can't take them due to GI side effects.

Zometa (zoledronic acid) is also a bisphosphonate, but it's given IV. It's recently approved for hypercalcemia and bone metastases in cancer patients.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote